Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8224111 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
This study supports the evaluation of newer generation Cdk inhibitors, such as AZD5438, as potent radiosensitizers in NSCLC models, especially in tumors that demonstrate variable intrinsic radiation responses.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Pavithra MS, Vasu BS, Lan PhD, Norman MD, PhD, Nozomi PhD, Sandeep PhD, Robert G. MD, PhD, Debabrata PhD,